Antidepressant action of tianeptine is connected with acceleration of serotonin turnover in the synapse: A hypothesis

Neuropsychopharmacologia Hungarica

Volumn 11, Issue 2, 2009, Pages 83-87

  Uzbekov, Marat G ^a  

^a Moscow Research Institute of Psychiatry   (Russian Federation)

Author keywords

Anxious depression; Neurochemical mechanisms of action; Tianeptine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); SEROTONIN UPTAKE INHIBITOR; TIANEPTINE;

ANXIETY; ARTICLE; DEPRESSION; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; MONOAMINERGIC SYSTEM; NEUROCHEMISTRY; PATHOPHYSIOLOGY; SEROTONIN METABOLISM; SEROTONIN RELEASE; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; HUMANS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; SEROTONIN; SYNAPSES; THIAZEPINES;

EID: 68349102938     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ansseau M, 1993. The paradox of tianeptine. Eur. Psychiatry 8 (suppl 2): 89-93.
2. Avakjan OM. 1976. Up-to-date data about the mechanisms of the release and reuptake of catecholamines; possibilities and perspectives of their pharmacological regulation. Mendeleev Zh Vsesouznogo Khimicheskogo Obshchestva 21: 165-171.
3. Bellivier F, Roy I, Leboyer M. 2002. Serotonin transporter gene polymorphisms and affective disorderrelated phenotypes. Curr Opin Psychiatry 15: 49-58.
4. Carlsson A, Corrodi H, Fuxe K, Hokfelt T. 1969. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-metyl-alfa-ethilmetatyramine. Eur. J. Pharmacol 5: 357-366.
5. Delbende C, Tranchand Bunel D, Tarozzo G, Grino M, Oliver C, Mocaer E, Vaudry H. 1994. Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo- pituitary-adrenal axis. Eur J Pharmacol 251: 245-251.
6. Droste SK, Schweizer MC, Ulbricht S, Reul JM. 2006. Long-term voluntary exercise and the mouse hypothalamic- pituitary-adrenocortical axis: impact of concurrent treatment with antidepressant drug tianeptine. J Neuroendocrinol 18: 915-925.
7. Fattaccini CM, Bolanos-Jimenez F, Golzan H, Hamon M. 1990. Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology 29: 1-8.
8. Hertz L, Tamir H. 1981. Some properties of an astrocyte protein fraction that binds serotonin. J. Neurochem 37: 1331-1334.
9. Hirschfeld RM. 2001. Clinical importance of long-term antidepressant treatment. Br J Psychiatry 42 (Suppl): S4-S8.
10. Hughes J. 1972. Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br. J. Pharma 44: 472-491.
11. Kasper S. 2001. Depression and Anxiety - Separate or Continuum. World J Biol Psychiatry 2: 162-163.
12. Kasper S. 2006. Neuroplasticity and the treatment of depression. Neuropsychiatric Disease and Treatment 2, Suppl 2: 15-20.
13. Kasper S, McEwen BS. 2008. Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs 22: 16-26.
14. Kato G, Weitsch AF. 1988. Neurochemical profile of tianeptine, a new antidepressant drug. Clin. Neuropharmacology 11 (suppl 2): 43-50.
15. Kelly JP, Leonard BE. 1994. The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology 33: 1011-1016.
16. Labrid C, Mocaer E, Kamoun A. 1992. Neurochemical and pharmacological properties of tianeptine, a novel antidepressant. Br J Psychiatry Suppl 15: 56-60.
17. Lucassen PJ, Fuchs E, Czeh B. 2004. Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 55: 789-796.
18. Marinesco S, Poncet L, Debilly G, Jouvet M, Cespuglio R. 1996. Effects of tianeptine, sertraline and clomipramine on brain serotonin metabolism: a voltammetric approach in the rat. Brain. Res 736: 82-90.
19. Maximova NM, Misionzhnik EY, Vertogradova OP, Uzbekov MG. 2000. Therapeutic efficacy and metabolic peculiarities in patients with depressive disorder under tianeptine (TIA) and sertraline (SER) treatment. Eur Psychiatry 15 (Suppl. 2): 379S.
20. Pineyro G, Deveault L, Blier P, Dennis T, de Montigny C. 1995. Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 351: 111-118.
21. Quitkin FM, Rabkin JG, Ross D, Mc Grath PJ. 1984. Duration of antidepressant drug treatment. What is an adequate trial? Arch. Gen. Psychiatry 41: 238-245.
22. Stahl SM. 1985. Peripheral models for the study of neurotransmitter receptors in man. Psychopharmacol. Bull 21: 663-671.
23. Stahl SM. 1999. Essential Psychopharmacology. Neuroscientific Basis and Clinical Applications. Cambridge University Press: Cambridge.
24. Stanley M, Virgilio J, Gershon S. 1982. Tritiated imipramine sites are decreased in the frontal cortex of suicides. Science 216: 1337-1339.
25. Uzbekov MG, Misionzhnik EY. 2000. Nonspecific syndrome of endogenous intoxication as an integral component of patogenesis of psychic disorders. Russian Journal of Psychiatry 1 4: 56-65.
26. Uzbekov MG, Misionzhnik EY, Maximova NM, Vertogradova OP. 2006. Biochemical profile in patients with anxious depression under the treatment with serotonergic antidepressants with different mechanisms of action. Hum Psychopharmacol Clin Exp 21: 109-115.
27. Uzbekov MG, Maximova NM, Misionzhnik EY, Vertogradova OP. 2002. About the neurochemical mechanism of tianeptine (coaxil) action in anxiety-depressed patients. Social and Clinical Psychiatry 12: 43-45.
28. Uzbekov MG, Misionhznik EY, Maximova NM, Vertogradova OP, Rizhov AM, Shikhov SN. 2003. Some aspects of metabolic disturbances in anxious depression. Russian Journal of Psychiatry No 6: 58-62.
29. Wagstaff AJ, Ormrod D, Spencer CM. 2001. Tianeptine: a review of its use in depressive disorders. CNS Drugs 15: 231-259.
30. Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen BS. 1992. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 222: 157-162.
31. Whitaker PM, Vint CK, Morin R. 1983. Imipramine labels sites on brain astroglial cells not related to serotonin uptake. J. Neurochem 41: 1319-1322.